AHA 2025: Gene therapy shows potential in chronic heart failure
Preclinical data with a gene therapy has shown potential to restore cardiac function in a rat model of for heart failure.
Drug Development
Harbour BioMed and Evinova collaborate on AI biologics
Pelthos acquires US rights to Xepi cream from Biofrontera and Ferrer
SanegeneBio and Lilly sign RNAi licence deal for metabolic diseases
Abzena and Mabqi partner for drug development solution
Cencora to invest $1bn in US pharma distribution network
Leukogene Therapeutics gains FDA ODD status for M2T-CD33
Avant and SGAustria form JV to develop diabetes therapy
